Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

7.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

14.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.0K
Composition of Blood01:22

Composition of Blood

14.9K
The blood in our bodies comprises three major components: blood plasma, formed elements, and the extracellular matrix. Blood plasma is a yellowish fluid that constitutes 55% of the total blood volume. It is primarily made up of water and essential substances such as electrolytes and proteins. Blood plasma serves as a medium for transporting blood cells and also contains nutrients, enzymes, hormones, antibodies, and gases.
Formed elements constitute the remaining 45% of the blood volume. These...
14.9K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Bulletin de l'Academie nationale de medecine·2016
Same author

Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasm.

Thrombosis research·2015
Same author

Spectrum of the mutations in Bernard-Soulier syndrome.

Human mutation·2014
Same author

Molecular determinants of platelet delta storage pool deficiencies: an update.

British journal of haematology·2012
Same author

The JAK2 46/1 haplotype in splanchnic vein thrombosis.

Blood·2011
Same author

Multiple intra-abdominal venous thrombosis in ulcerative colitis: role of MDCT for detection.

Clinical imaging·2011

Related Experiment Video

Updated: Apr 28, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

19.4K

[Blood platelets].

Jacques Caen, Sylvia Bellucci

    Bulletin De L'Academie Nationale De Medecine
    |June 13, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Inherited platelet disorders research advances platelet physiology knowledge, enabling antiplatelet drug development for vascular diseases. Understanding megakaryocytopoiesis also informs new treatments like thrombopoietin analogs for immune thrombocytopenias.

    More Related Videos

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
    09:38

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

    Published on: February 14, 2017

    16.3K
    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
    11:18

    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

    Published on: April 2, 2013

    15.0K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
    09:46

    Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

    Published on: December 27, 2017

    19.4K
    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
    09:38

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

    Published on: February 14, 2017

    16.3K
    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
    11:18

    Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

    Published on: April 2, 2013

    15.0K

    Area of Science:

    • Hematology
    • Vascular Biology
    • Platelet Physiology

    Context:

    • Inherited platelet disorders provide critical insights into platelet function.
    • Advances in understanding platelet physiology have direct clinical applications.
    • Megakaryocytopoiesis research is crucial for developing novel therapeutics.

    Purpose:

    • To highlight the impact of studying inherited platelet disorders on platelet physiology.
    • To discuss the development of antiplatelet agents for vascular diseases.
    • To explore new therapeutic strategies derived from megakaryocytopoiesis research.

    Summary:

    • Research into inherited platelet disorders has significantly advanced the understanding of platelet physiology.
    • This knowledge has enabled the creation of antiplatelet agents, now standard in treating vascular diseases.
    • Improved comprehension of megakaryocytopoiesis has led to innovative treatments, such as thrombopoietin analogs for immune thrombocytopenias.

    Impact:

    • Led to the development of widely used antiplatelet agents for vascular diseases.
    • Provided a foundation for new therapeutic strategies in hematology.
    • Enhanced treatment options for immune thrombocytopenias through thrombopoietin analog research.